Gastrointestinal toxicity of gemtuzumab ozogamicin: real-life data from the AMLCG, SAL, and CELL study groups - Ricarda Knabe; Philippe Muller; Christoph Schliemann; Maher Hanoun; Julia Marie Unglaub; Barbora Weinbergerová; Jiří Mayer; Carolin Krekeler; Stefan W. Krause; Martin Kaufmann; Sabrina Kraus; Björn Steffen; et al. (Blood Advances)